Virtual Biotech Company Puts 37,000 AI Agents to Work on Drug Discovery
Stanford researchers deploy thousands of digital lab assistants to revolutionize pharmaceutical development.
The system, designed by Stanford researchers, identified which drugs are more likely to succeed in trials and even proposed a cancer treatment a major drugmaker later landed on too. The post Virtual Biotech Company Puts 37,000 AI Agents to Work on Drug Discovery appeared first on...
Singularity Hub
Source
Generated insight by OnAirToday AI
Using thousands of autonomous agents to simulate drug interactions dramatically accelerates the R&D timeline by weeding out ineffective compounds before costly clinical trials begin. This shift from manual research to multi-agent synthetic biology marks a fundamental change in how we combat complex diseases like cancer.
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.